An Msh2 Point Mutation Uncouples DNA Mismatch Repair and Apoptosis

Cancer Research

Volumn 64, Issue 2, 2004, Pages 517-522

  Lin, Diana P ^a   Wang, Yuxun ^a   Scherer, Stefan J ^a   Clark, Alan B ^b   Yang, Kan ^c   Avdievich, Elena ^a   Jin, Bo ^a   Werling, Uwe ^a   Parris, Tchaiko ^a   Kurihara, Naoto ^c   Umar, Asad ^b   Kucherlapati, Raju ^d   Lipkin, Martin ^c   Kunkel, Thomas A ^b   Edelmann, Winfried ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d Harvard Partners Center for Genetics and Genomics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC AGENT; CISPLATIN; PROTEIN MSH2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA DAMAGE; DRUG SENSITIVITY; FEMALE; GENE INACTIVATION; GENOTOXICITY; MALE; MISMATCH REPAIR; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TERATOCARCINOMA; TUMOR RESISTANCE;

ALANINE; AMINO ACID SUBSTITUTION; ANIMALS; APOPTOSIS; BASE PAIR MISMATCH; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CISPLATIN; CODON; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FIBROBLASTS; GLYCINE; MICE; MUTS HOMOLOG 2 PROTEIN; POINT MUTATION; PROTO-ONCOGENE PROTEINS; SEQUENCE DELETION;

EID: 9144227402     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2957     Document Type: Article

References (52)

1. Peltomaki, P., and Vasen, H. F. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology, 113: 1146-1158, 1997.
2. Kolodner, R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev., 10: 1433-1442, 1996.
3. Modrich, P. Strand-specific mismatch repair in mammalian cells. J. Biol. Chem., 272: 24727-24730, 1997.
4. Buermeyer, A. B., Deschênes, S. M., Baker. S. M., and Liskay, R. M. Mammalian mismatch repair. Annu. Rev. Genet., 33: 533-564, 1999.
5. Karran, P., and Bignami, M. DNA damage tolerance, mismatch repair and genome instability. Bioessays, 16: 833-839, 1994.
6. Aebi, S., Kurdi-Haidar, B., Gordon, R., Cenni, B., Zheng, H., Fink, D., Christen, R. D., Boland, C. R., Koi, M., Fishel, R., and Howell, S. B. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res., 56: 3087-3090, 1996.
7. Umar, A., Koi, M., Risinger, J. I., Glaab, W. E., Tindall, K. R., Kolodner, R. D., Boland, C. R., Barrett, J. C., and Kunkel, T. A. Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res., 57: 3949-3955, 1997.
8. D'Atri, S., Tentori, L., Lacal, P. M., Graziani, G., Pagani, E., Benincasa, E., Zambruno, G., Bonmassar, E., and Jiricny, J. Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol. Pharmacol., 54: 334-341, 1998.
9. Hickman, M. J., and Samson. L. D. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl. Acad. Sci. USA, 96: 10764-10769, 1999.
10. Toft, N. J., Winton, D. J., Kelly, J., Howard, L. A., Dekker, M., te Riele, H., Arends, M. J., Wyllie, A. H., Margison, G. P., and Clarke, A. R. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. Proc. Natl. Acad. Sci. USA, 96: 3911-3915, 1999.
11. Ni, T. T., Marsischky, G. T., and Kolodner, R. D. MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-guanine in S. cerevisiae. Mol. Cell. 4: 439-444, 1999.
12. Colussi, C., Parlanti, E., Degan, P., Aquilina, G., Barnes, D., Macpherson, P., Karran, P., Crescenzi, M., Dogliotti, E., and Biguami, M. The mammalian mismatch repair pathway removes DNA 8-oxodGMP incorporated from the oxidized dNTP pool. Curr. Biol., 12: 912-918, 2002.
13. Drummond, J. T., Anthoney, A., Brown, R., and Modrich, P. Cisplatin and Adriamycin resistance are associated with MutLα and mismatch repair deficiency in an ovarian tumor cell line. J. Biol. Chem., 271: 19645-19648, 1996.
14. Glaab, W. E., Risinger, J. I., Umar, A., Barrett, J. C., Kunkel, T. A., and Tindall, K. R. Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus. Carcinogenesis (Lond.), 19: 1931-1937, 1998.
15. Colussi, C., Fiumicino, S., Giuliani, A., Rosini, S., Musiani, P., Macri, C., Potten, C. S., Crescenzi, M., and Bignami, M. 1, 2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice. J. Natl. Cancer Inst. (Bethesda), 93: 1534-1540, 2001.
16. Fishel, R. The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis. Cancer Res., 61: 7369-7374, 2001.
17. Andrew, S. E., McKinnon, M., Cheng, B. S., Francis, A., Penney, J., Reitmair, A. H., Mak, T. W., and Jirik, F. R. Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent. Proc. Natl. Acad. Sci. USA, 95: 1126-1130, 1998.
18. Gorbalenya, A. E., and Koonin, E. V. Superfamily of UvrA-related NTP-binding proteins. Implications for rational classification of recombination/repair systems. J. Mol. Biol., 213: 583-591, 1990.
19. Pai, E. F., Krengel, U., Petsko, G. A., Goody, R. S., Kabsch, W., and Wittinghofer, A. Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 Å resolution: implications for the mechanism of GTP hydrolysis. EMBO J., 9: 2351-2359, 1990.
20. Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. Distantly related sequences in the α- and β-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J., 1: 945-951, 1982.
21. Wu, T. H., and Marinus, M. G. Dominant negative mutator mutations in the mutS gene of Escherichia coli. J. Bacteriol., 176: 5393-5400, 1994.
22. Alani, E., Sokolsky, T., Studamire, B., Miret, J. J., and Lahue, R. S. Genetic and biochemical analysis of Msh2p-Msh6p: role of ATP hydrolysis and Msh2p-Msh6p subunit interactions in mismatch base pair recognition. Mol. Cell. Biol., 17: 2436-2447, 1997.
23. Iaccarino, I., Marra, G., Palombo, F., and Jiricny, J. hMSH2 and hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMutSα. EMBO J., 17: 2677-2686, 1998.
24. Drotschmann, K., Clark, A. B., Tran, H. T., Resnick, M. A., Gordenin, D. A., and Kunkel, T. A. Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene. Proc. Natl. Acad. Sci. USA, 96: 2970-2975, 1999.
25. Obmolova, G., Ban, C., Hsieh, P., and Yang, W. Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA. Nature (Lond.), 407: 703-710, 2000.
26. Zhang, Y., Buchholz, F., Muyrers, J. P., and Stewart, A. F. A new logic for DNA engineering using recombination in Escherichia coli. Nat. Genet., 20: 123-128, 1998.
27. Ioffe, E., Liu, Y., Bhaumik, M., Poirier, F., Factor, S. M., and Stanley, P. WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras. Proc. Natl. Acad. Sci. USA. 92: 7357-7361, 1995.
28. Umar, A., Buermeyer, A. B., Simon, J. A., Thomas, D. C., Clark, A. B., Liskay, R. M., and Kunkel, T. A. Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell. 87: 65-73, 1996.
29. Thomas, D. C., Umar, A., and Kunkel, T. A. Measurement of heteroduplex repair in human cell extracts. In: E. C. Friedberg (ed.), Methods: A Companion to Methods in Enzymology, pp. 187-197. New York: Academic Press, 1995.
30. Wong, E., Yang, K., Kuraguchi, M., Werling, U., Avdievich, E., Fan, K., Fazzari, M., Jin, B., Brown, A. M., Lipkin, M., and Edelmann, W. Mbd4 inactivation increases C→T transition mutations and promotes gastrointestinal tumor formation. Proc. Natl. Acad. Sci. USA. 99: 14937-14942, 2002.
31. Palombo, F., Gallinari, P., Iaccarino, I., Lettieri, T., Hughes, M., D'Arrigo, A., Truong, O., Hsuan, J. J., and Jiricny, J. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science (Wash. DC), 268: 1912-1914, 1995.
32. Marsischky, G. T., Filosi, N., Kane, M. F., and Kolodner, R. Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair. Genes Dev., 10: 407-420, 1996.
33. Palombo, F., Iaccarino, I., Nakajima, E., Ikejima, M., Shimada, T., and Jiricny, J. hMutSβ, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA. Curr. Biol., 6: 1181-1184, 1996.
34. Genschel, J., Littman, S. J., Drummond, J. T., and Modrich, P. Isolation of MutSβ from human cells and comparison of the mismatch repair specificities of MutSβ and MutSα. J. Biol. Chem., 273: 19895-19901, 1998.
35. Guerrette, S., Wilson, T., Gradia, S., and Fishel, R. Interactions of human hMSH2 with hMSH3 and hMSH2 with hMSH6: examination of mutations found in hereditary nonpolyposis colorectal cancer. Mol. Cell. Biol., 18: 6616-6623, 1998.
36. Umar, A., Risinger, J. I., Glaab, W. E., Tindall, K. R., Barrett, J. C., and Kunkel, T. A. Functional overlap in mismatch repair by human MSH3 and MSH6. Genetics, 148: 1637-1646, 1998.
37. Kuraguchi, M., Yang, K., Wong, E., Avdievich, E., Fan, K., Kolodner, R. D., Lipkin, M., Brown, A. M., Kucherlapati, R., and Edelmann, W. The distinct spectra of tumor-associated Apc mutations in mismatch repair-deficient Apc1638N mice define the roles of MSH3 and MSH6 in DNA repair and intestinal tumorigenesis. Cancer Res., 61: 7934-7942, 2001.
38. de Leeuw, W. J., Dierssen, J., Vasen, H. F., Wijnen, J. T., Kenter, G. G., Meijers-Heijboer, H., Brocker-Vriends, A., Stormorken, A., Moller, P., Menko, F., Comelisse, C. J., and Morreau, H. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. J. Pathol., 192: 328-335, 2000.
39. Wei, K., Clark, A. B., Wong, E., Kane, M. F., Mazur, D. J., Parris, T., Kolas, N. K., Russell, R., Hou, H., Jr., Kneitz, B., Yang, G., Kunkel, T. A., Kolodner, R. D., Cohen, P. E., and Edelmann, W. Inactivation of exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility. Genes Dev., 17: 603-614, 2003.
40. Reitmair, A. H., Redston, M., Cai, J. C., Chuang, T. C., Bjerknes, M., Cheng, H., Hay, K., Gallinger, S., Bapat, B., and Mak, T. W. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res., 56: 3842-3849, 1996.
41. de Wind, N., Dekker, M., van Rossum, A., van der Valk, M., and te Riele, H. Mouse models for hereditary nonpolyposis colorectal cancer. Cancer Res., 58: 248-255, 1998.
42. Smits, R., Hofland, N., Edelmann, W., Geugien, M., Jagmohan-Changur, S., Albuquerque, C., Breukel, C., Kucherlapati, R., Kielman, M. F., and Fodde, R. Somatic apc mutations are selected upon their capacity to inactivate the β-catenin downregulating activity. Genes Chromosomes Cancer, 29: 229-239, 2000.
43. Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA, 78: 7634-7638, 1981.
44. Fink, D., Zheng, H., Nebel, S., Norris, P. S., Aebi, S., Lin, T. P., Nehme, A., Christen, R. D., Haas, M., MacLeod, C. L., and Howell, S. B. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res., 57: 1841-1845, 1997.
45. Zhang, H., Richards, B., Wilson, T., Lloyd, M., Cranston, A., Thorbum, A., Fishel, R., and Meuth, M. Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res., 59: 3021-3027, 1999.
46. Heinen, C. D., Schmutte, C., and Fishel, R. DNA repair and tumorigenesis: lessons from hereditary cancer syndromes. Cancer Biol. Ther., 1: 477-485, 2002.
47. Li, G. M. The role of mismatch repair in DNA damage-induced apoptosis. Oncol. Res., 11: 393-400, 1999.
48. Kat, A., Thilly, W. G., Fang, W. H., Longley, M. J., Li, G. M., and Modrich, P. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA, 90: 6424-6428, 1993.
49. Brown, K. D., Rathi, A., Kamath, R., Beardsley, D. I., Zhan, Q., Mannino, J. L., and Baskaran, R. The mismatch repair system is required for S-phase checkpoint activation. Nat. Genet., 33: 80-84, 2003.
50. Gong, J. G., Costanzo, A., Yang, H. Q., Melino, G., Kaelin, W. G., Jr., Levrero, M., and Wang, J. Y. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature (Lond.), 399: 806-809, 1999.
51. Shimodaira, H., Yoshioka-Yamashita, A., Kolodner, R. D., and Wang, J. Y. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc. Natl. Acad. Sci. USA, 100: 2420-2425, 2003.
52. Thomas, D. C., Roberts, J. D., and Kunkel, T. A. Heteroduplex repair in extracts of human HeLa cells. J. Biol. Chem., 266: 3744-3751, 1991.